{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:00:51Z","timestamp":1790852451054,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801809"],"award-info":[{"award-number":["81801809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371917"],"award-info":[{"award-number":["82371917"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515010572"],"award-info":[{"award-number":["2020A1515010572"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032579","name":"Beijing Medical Award Foundation","doi-asserted-by":"publisher","award":["YXJL-2024-0350-0255"],"award-info":[{"award-number":["YXJL-2024-0350-0255"]}],"id":[{"id":"10.13039\/100032579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.acra.2026.03.035","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:12:47Z","timestamp":1776201167000},"page":"4537-4547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging Immune Heterogeneity in Nasopharyngeal Carcinoma: A Multidimensional Radiomics Perspective"],"prefix":"10.1016","volume":"33","author":[{"given":"Jiaxin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-8882","authenticated-orcid":false,"given":"Yaqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2026.03.035_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10555-024-10176-9","article-title":"Epidemiology of nasopharyngeal carcinoma: current insights and future outlook","volume":"43","author":"Su","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.acra.2026.03.035_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","article-title":"Nasopharyngeal carcinoma: an evolving paradigm","volume":"18","author":"Wong","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib3","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1128\/JVI.78.13.7131-7137.2004","article-title":"Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia","volume":"78","author":"Burrows","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.acra.2026.03.035_bib4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41467-021-21795-z","article-title":"Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma","volume":"12","author":"Gong","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.acra.2026.03.035_bib5","first-page":"191","article-title":"The relationship between Tumor-infiltrating Lymphocytes (TILs) and Nasopharyngeal Carcinoma (NPC): a systematic review","volume":"33","author":"Prasetyo","year":"2021","journal-title":"Iran J Otorhinolaryngol"},{"key":"10.1016\/j.acra.2026.03.035_bib6","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.acra.2026.03.035_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-023-01928-2","article-title":"Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.acra.2026.03.035_bib8","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201628RR","article-title":"The immune escape mechanism of nasopharyngeal carcinoma","volume":"37","author":"Li","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.acra.2026.03.035_bib9","article-title":"Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes","volume":"6","author":"Yeo","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.acra.2026.03.035_bib10","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study","volume":"19","author":"Sun","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1159\/000515441","article-title":"Spatial intratumoral heterogeneity expression of PD-L1 antigen in head and neck squamous cell carcinoma","volume":"99","author":"Hirshoren","year":"2021","journal-title":"Oncology"},{"key":"10.1016\/j.acra.2026.03.035_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1497279","article-title":"Investigating subregional PD-L1 expression within primary tumors to predict clinical outcomes in advanced NSCLC patients who received ICB-based therapy","volume":"15","author":"Zhou","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.6004\/jnccn.2025.0043","article-title":"NCCN guidelines(R) insights: non-small cell lung cancer, version 7.2025","volume":"23","author":"Riely","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.acra.2026.03.035_bib14","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.acra.2026.03.035_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13058-024-01776-y","article-title":"Development of a machine learning-based radiomics signature for estimating breast cancer TME phenotypes and predicting anti-PD-1\/PD-L1 immunotherapy response","volume":"26","author":"Han","year":"2024","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.acra.2026.03.035_bib16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41416-019-0449-y","article-title":"Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma","volume":"120","author":"Rasmussen","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.acra.2026.03.035_bib17","first-page":"710","article-title":"[Consensus on the immunohistochemical tests of PD-L1 in solid tumors (2021 version)]","volume":"50","author":"Pathology Quality Control C","year":"2021","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.acra.2026.03.035_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00428-022-03322-7","article-title":"PD-L1 expression in head and neck carcinoma by combined positive score: a comparison among preoperative biopsy, tumor resection, and lymph node metastasis","volume":"481","author":"Ambrosini-Spaltro","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.acra.2026.03.035_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/PAI.0000000000001140","article-title":"Comparison of PD-L1 IHC 22C3 PharmDx Combined Positive Score (CPS) in primary versus metastatic nodal squamous cell carcinomas of the head and neck: is there a significant difference?","volume":"31","author":"Surucu","year":"2023","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.acra.2026.03.035_bib20","article-title":"Immune microenvironment change and involvement of circular RNAs in TIL cells of recurrent nasopharyngeal carcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.acra.2026.03.035_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/his.13946","article-title":"Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma","volume":"76","author":"Downes","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.acra.2026.03.035_bib22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/his.14775","article-title":"High interobserver and intraobserver reproducibility among pathologists assessing PD-L1 CPS across multiple indications","volume":"81","author":"Nuti","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.acra.2026.03.035_bib23","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41379-020-0644-7","article-title":"Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)","volume":"34","author":"de Ruiter","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.acra.2026.03.035_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.640515","article-title":"Performance of different diagnostic PD-L1 clones in head and neck squamous cell carcinoma","volume":"8","author":"Ribbat-Idel","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.acra.2026.03.035_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104935","article-title":"The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma","volume":"108","author":"Park","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib26","article-title":"Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.acra.2026.03.035_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41392-024-01988-w","article-title":"Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trials","volume":"9","author":"Huang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.acra.2026.03.035_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100336","article-title":"Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers","volume":"7","author":"Palmeri","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.acra.2026.03.035_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.03.035_bib30","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.acra.2026.03.035_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12967-023-04437-4","article-title":"Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis","volume":"21","author":"Kang","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.acra.2026.03.035_bib32","doi-asserted-by":"crossref","DOI":"10.34133\/research.0749","article-title":"Radiomic model associated with tumor microenvironment predicts immunotherapy response and prognosis in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"8","author":"Sun","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.acra.2026.03.035_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12967-024-05880-7","article-title":"Unveiling immune resistance mechanisms in nasopharyngeal carcinoma and emerging targets for antitumor immune response: tertiary lymphoid structures","volume":"23","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.acra.2026.03.035_bib34","article-title":"Deep learning-based quantification of tumor-infiltrating lymphocytes as a prognostic indicator in nasopharyngeal carcinoma: multicohort findings","volume":"10","author":"Lu","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.acra.2026.03.035_bib35","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/jnci\/djae081","article-title":"Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma","volume":"116","author":"Lin","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.acra.2026.03.035_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00432-023-05590-5","article-title":"CT-based peritumoral radiomics nomogram on prediction of response and survival to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma","volume":"150","author":"Zeng","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib37","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1038\/s41467-023-38407-7","article-title":"Clinical efficacy and biomarker analysis of dual PD-1\/CTLA-4 blockade in recurrent\/metastatic EBV-associated nasopharyngeal carcinoma","volume":"14","author":"Lim","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.acra.2026.03.035_bib38","article-title":"Correlation of PD-L1 expression of tumor cells with survival outcomes after radical intensity-modulated radiation therapy for non-metastatic nasopharyngeal carcinoma","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.acra.2026.03.035_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12105-016-0765-y","article-title":"Programmed death-ligand 1 expression, microsatellite instability, Epstein-Barr virus, and human papillomavirus in nasopharyngeal carcinomas of patients from the Philippines","volume":"11","author":"Chang","year":"2017","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.acra.2026.03.035_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10585-018-9950-6","article-title":"Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases","volume":"36","author":"Manson","year":"2019","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.acra.2026.03.035_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semcancer.2022.08.002","article-title":"Artificial intelligence-based prediction of clinical outcome in immunotherapy and targeted therapy of lung cancer","volume":"86","author":"Yin","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.acra.2026.03.035_bib42","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/cancers14061370","article-title":"Application of artificial intelligence in lung cancer","volume":"14","author":"Chiu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.acra.2026.03.035_bib43","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1007\/s00330-022-08651-4","article-title":"A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma","volume":"32","author":"Zheng","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.03.035_bib44","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00259-019-04654-4","article-title":"Usefulness of [(18)F]fluorodeoxyglucose PET\/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma","volume":"47","author":"Zhao","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2026.03.035_bib45","first-page":"447","article-title":"Evaluation of PD-L1 expression status in nasopharyngeal carcinoma by 18F-FDG PET\/CT radiomics analysis","volume":"23","author":"Yang","year":"2025","journal-title":"Int\u00a0J\u00a0Radiat\u00a0Res"},{"key":"10.1016\/j.acra.2026.03.035_bib46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12880-025-01917-5","article-title":"Dynamic contrast-enhanced magnetic resonance imaging-based radiomics for predicting programmed death ligand 1 expression in nasopharyngeal carcinoma","volume":"25","author":"Li","year":"2025","journal-title":"BMC Med Imaging"},{"key":"10.1016\/j.acra.2026.03.035_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40644-023-00587-2","article-title":"Reproducibility and usefulness of quantitative apparent diffusion coefficient measurements for predicting program death-ligand 1 expression in nasopharyngeal carcinoma","volume":"23","author":"Zhong","year":"2023","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.acra.2026.03.035_bib48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10549-020-05655-w","article-title":"PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies","volume":"181","author":"Stovgaard","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.acra.2026.03.035_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.lungcan.2019.06.005","article-title":"Heterogeneity of PD-L1 expression in non-small cell lung cancer: implications for specimen sampling in predicting treatment response","volume":"134","author":"Haragan","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.acra.2026.03.035_bib50","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2147\/CMAR.S193878","article-title":"Mismatch repair status and high expression of PD-L1 in nasopharyngeal carcinoma","volume":"11","author":"Zhao","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.acra.2026.03.035_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41698-024-00558-1","article-title":"Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma","volume":"8","author":"Ma","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib52","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.21037\/atm-21-5175","article-title":"The clinical prognostic value of PD-L1 after concurrent chemoradiotherapy in Chinese nasopharyngeal carcinoma patients","volume":"9","author":"Long","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.acra.2026.03.035_bib53","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11547-024-01853-4","article-title":"Delta radiomics: an updated systematic review","volume":"129","author":"Nardone","year":"2024","journal-title":"Radiol Med"},{"key":"10.1016\/j.acra.2026.03.035_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2023.100511","article-title":"Delta-radiomics in cancer immunotherapy response prediction: a systematic review","volume":"11","author":"Abbas","year":"2023","journal-title":"Eur J Radiol Open"},{"key":"10.1016\/j.acra.2026.03.035_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009140","article-title":"Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction","volume":"13","author":"Bernatowicz","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.acra.2026.03.035_bib56","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s00330-025-11350-5","article-title":"Prediction of immunotherapy response in nasopharyngeal carcinoma: a comparative study using MRI-based radiomics signature and programmed cell death ligand 1 expression score","volume":"35","author":"Mai","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.03.035_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102245","article-title":"MRI-based deep learning and radiomics for predicting the efficacy of PD-1 inhibitor combined with induction chemotherapy in advanced nasopharyngeal carcinoma: a prospective cohort study","volume":"52","author":"Wang","year":"2025","journal-title":"Transl Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111010","article-title":"Multimodal prognostic model for de novo metastatic nasopharyngeal carcinoma after first-line immunochemotherapy","volume":"210","author":"Liu","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12967-023-04004-x","article-title":"Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1\/PD-L1 immunotherapy in advanced NSCLC patients","volume":"21","author":"Farina","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.acra.2026.03.035_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.990608","article-title":"Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy","volume":"12","author":"Xie","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib61","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.21037\/tlcr-24-7","article-title":"Predictive value of delta-radiomic features for prognosis of advanced non-small cell lung cancer patients undergoing immune checkpoint inhibitor therapy","volume":"13","author":"Han","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.acra.2026.03.035_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.824509","article-title":"Prediction of response to induction chemotherapy plus concurrent chemoradiotherapy for nasopharyngeal carcinoma based on MRI radiomics and delta radiomics: a two-center retrospective study","volume":"12","author":"Xi","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib63","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/diagnostics14090941","article-title":"Utility of CT radiomics and delta radiomics for survival evaluation in locally advanced nasopharyngeal carcinoma with concurrent chemoradiotherapy","volume":"14","author":"Huang","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.acra.2026.03.035_bib64","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.21037\/qims.2019.07.08","article-title":"Early prediction of acute xerostomia during radiation therapy for nasopharyngeal cancer based on delta radiomics from CT images","volume":"9","author":"Liu","year":"2019","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.acra.2026.03.035_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1654023","article-title":"Multimodal MRI-based radiomics model for predicting short-term efficacy in nasopharyngeal carcinoma","volume":"12","author":"Zhuang","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.acra.2026.03.035_bib66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41698-024-00534-9","article-title":"A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?","volume":"8","author":"Ligero","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib67","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.03.035_bib68","first-page":"321","article-title":"Reproducibility and interpretability in radiomics: a critical assessment","volume":"31","author":"Demircioglu","year":"2025","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.acra.2026.03.035_bib69","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1007\/s00330-020-07598-8","article-title":"Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers","volume":"31","author":"Fournier","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.03.035_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.103629","article-title":"Deep learning-based segmentation of breast masses in dedicated breast CT imaging: Radiomic feature stability between radiologists and artificial intelligence","volume":"118","author":"Caballo","year":"2020","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.acra.2026.03.035_bib71","doi-asserted-by":"crossref","first-page":"339","DOI":"10.23736\/S1824-4785.19.03217-5","article-title":"Integrating radiomics into clinical trial design","volume":"63","author":"Waninger","year":"2019","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.acra.2026.03.035_bib72","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1088\/0031-9155\/61\/13\/R150","article-title":"Applications and limitations of radiomics","volume":"61","author":"Yip","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.acra.2026.03.035_bib73","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.acra.2026.03.035_bib74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1109\/TBME.2018.2828304","article-title":"Registration accuracy of patient-specific, three-dimensional-printed prostate molds for correlating pathology with magnetic resonance imaging","volume":"66","author":"Priester","year":"2019","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1016\/j.acra.2026.03.035_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2020.101919","article-title":"ProsRegNet: a deep learning framework for registration of MRI and histopathology images of the prostate","volume":"68","author":"Shao","year":"2021","journal-title":"Med Image Anal"},{"key":"10.1016\/j.acra.2026.03.035_bib76","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2021219005","article-title":"The biological meaning of radiomic features","volume":"299","author":"Tomaszewski","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.03.035_bib77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.4448","article-title":"The role of Epstein-Barr virus in epithelial malignancies","volume":"235","author":"Tsao","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.acra.2026.03.035_bib78","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1976439","article-title":"Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients","volume":"10","author":"Wang","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.acra.2026.03.035_bib79","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acra.2026.03.035_bib80","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41698-024-00656-0","article-title":"Radiology and multi-scale data integration for precision oncology","volume":"8","author":"Paverd","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib81","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1038\/s41598-017-05848-2","article-title":"Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2026.03.035_bib82","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1007\/s00330-019-06024-y","article-title":"Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling","volume":"29","author":"Jia","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2026.03.035_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-96821-x","article-title":"Interplay between MRI radiomics and immune gene expression signatures in oral squamous cell carcinoma","volume":"15","author":"Corti","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.acra.2026.03.035_bib84","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41586-022-05249-0","article-title":"Single-cell genomic variation induced by mutational processes in cancer","volume":"612","author":"Funnell","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.acra.2026.03.035_bib85","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12943-025-02400-z","article-title":"Overcoming resistance to anti-PD-L1 immunotherapy: mechanisms, combination strategies, and future directions","volume":"24","author":"Mandal","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.acra.2026.03.035_bib86","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i7.108175","article-title":"Deep learning radiomics: redefining precision oncology through noninvasive insights into the tumor immune microenvironment","volume":"17","author":"Tez","year":"2025","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib87","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i5.106103","article-title":"Computed tomography-based deep learning radiomics model for preoperative prediction of tumor immune microenvironment in colorectal cancer","volume":"17","author":"Zhou","year":"2025","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.acra.2026.03.035_bib88","article-title":"Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors","volume":"13","author":"Park","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.acra.2026.03.035_bib89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13244-023-01437-2","article-title":"An overview of meta-analyses on radiomics: more evidence is needed to support clinical translation","volume":"14","author":"Zhong","year":"2023","journal-title":"Insights Imaging"},{"key":"10.1016\/j.acra.2026.03.035_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111438","article-title":"Nomograms based on multiparametric MRI radiomics integrated with clinical-radiological features for predicting the response to induction chemotherapy in nasopharyngeal carcinoma","volume":"175","author":"Chen","year":"2024","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.acra.2026.03.035_bib91","doi-asserted-by":"crossref","first-page":"e644","DOI":"10.1016\/j.crad.2023.05.012","article-title":"Radiomic analysis of MRI for prediction of response to induction chemotherapy in nasopharyngeal carcinoma patients","volume":"78","author":"Wang","year":"2023","journal-title":"Clin Radiol"},{"key":"10.1016\/j.acra.2026.03.035_bib92","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/bioengineering12111139","article-title":"Radiomics in action: multimodal synergies for imaging biomarkers","volume":"12","author":"Flaiban","year":"2025","journal-title":"Bioengineering"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226002333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226002333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:50:36Z","timestamp":1790851836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226002333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":92,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1076633226002333"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.03.035","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging Immune Heterogeneity in Nasopharyngeal Carcinoma: A Multidimensional Radiomics Perspective","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}